Lunai Bioworks (LNAI) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($5.1 million vs $5.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LNAI | RDHL |
|---|---|---|
| Share price | $1.12 | $0.578 |
| Market cap | $5.08M | $5.14M |
| 1-day change | +2.75% | +21.94% |
| Forward P/E | — | 19.27 |
| EPS (TTM) | $-61.36 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.28 | $2.14 |
| 52-week low | $1.08 | $0.435 |
| Distance from 52-week high | -91.57% | -72.99% |
| Average volume | 181.37K | 2.05M |
| Shares outstanding | 4.53M | 8.89M |
| Employees | 29 | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lunai Bioworks
LNAI stock →Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC.
Healthcare · Biotechnology · 29 employees
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 13 employees
LNAI vs RDHL FAQ
Which is bigger, Lunai Bioworks or Redhill Biopharma?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $5.14M compared with $5.08M for Lunai Bioworks (LNAI).
Are Lunai Bioworks and Redhill Biopharma in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Lunai Bioworks and Drug Manufacturers - Specialty & Generic for Redhill Biopharma.